The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The global Biological Drugs market size is projected to reach US$ 508960 million by 2027, from US$ 317190 million in 2020, at a CAGR of 8.2% during 2022-2027.
The global Biological Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
The world biological drugs market is predicted to gain momentum with rising prevalence of chronic diseases such as cancer and diabetes across the globe. Demand for biological drugs could swell with the expansion of geriatric population at the global level. Currently growing inclination toward adoption of personalized medicines and strong research and development efforts taken to introduce new and powerful biological drugs are foretold to set the tone for a significant rise in demand.
Geographical Analysis:
Based on region, the global Biological Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Biological Drugs market are
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Segment by Type
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Biological Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Biological Drugs market.
• The market share of the global Biological Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Biological Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Biological Drugs market.
The global Biological Drugs market size is projected to reach US$ 508960 million by 2027, from US$ 317190 million in 2020, at a CAGR of 8.2% during 2022-2027.
The global Biological Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
The world biological drugs market is predicted to gain momentum with rising prevalence of chronic diseases such as cancer and diabetes across the globe. Demand for biological drugs could swell with the expansion of geriatric population at the global level. Currently growing inclination toward adoption of personalized medicines and strong research and development efforts taken to introduce new and powerful biological drugs are foretold to set the tone for a significant rise in demand.
Geographical Analysis:
Based on region, the global Biological Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Biological Drugs market are
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Segment by Type
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Biological Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Biological Drugs market.
• The market share of the global Biological Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Biological Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Biological Drugs market.
1 Biological Drugs Market Overview
1.1 Biological Drugs Product Scope
1.2 Biological Drugs Segment by Type
1.2.1 Global Biological Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Therapeutic Protein
1.2.3 Monoclonal Antibody
1.2.4 Vaccine
1.2.5 Others
1.3 Biological Drugs Segment by Application
1.3.1 Global Biological Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Biological Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Biological Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Biological Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Biological Drugs Price Trends (2016-2027)
2 Biological Drugs Estimates and Forecasts by Region
2.1 Global Biological Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Biological Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Biological Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Biological Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Biological Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Biological Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Biological Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Biological Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Biological Drugs Estimates and Projections (2016-2027)
2.4.3 China Biological Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Biological Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Biological Drugs Estimates and Projections (2016-2027)
2.4.6 India Biological Drugs Estimates and Projections (2016-2027)
3 Global Biological Drugs Competition Landscape by Players
3.1 Global Top Biological Drugs Players by Sales (2016-2021)
3.2 Global Top Biological Drugs Players by Revenue (2016-2021)
3.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological Drugs as of 2020)
3.4 Global Biological Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Biological Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Biological Drugs Market Size by Type
4.1 Global Biological Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Biological Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Biological Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Biological Drugs Price by Type (2016-2021)
4.2 Global Biological Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Biological Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Biological Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Biological Drugs Price Forecast by Type (2022-2027)
5 Global Biological Drugs Market Size by Application
5.1 Global Biological Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Biological Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Biological Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Biological Drugs Price by Application (2016-2021)
5.2 Global Biological Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Biological Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Biological Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Biological Drugs Price Forecast by Application (2022-2027)
6 North America Biological Drugs Market Facts & Figures
6.1 North America Biological Drugs Sales by Company
6.1.1 North America Biological Drugs Sales by Company (2016-2021)
6.1.2 North America Biological Drugs Revenue by Company (2016-2021)
6.2 North America Biological Drugs Sales Breakdown by Type
6.2.1 North America Biological Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Biological Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Biological Drugs Sales Breakdown by Application
6.3.1 North America Biological Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Biological Drugs Sales Breakdown by Application (2022-2027)
7 Europe Biological Drugs Market Facts & Figures
7.1 Europe Biological Drugs Sales by Company
7.1.1 Europe Biological Drugs Sales by Company (2016-2021)
7.1.2 Europe Biological Drugs Revenue by Company (2016-2021)
7.2 Europe Biological Drugs Sales Breakdown by Type
7.2.1 Europe Biological Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Biological Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Biological Drugs Sales Breakdown by Application
7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)
8 China Biological Drugs Market Facts & Figures
8.1 China Biological Drugs Sales by Company
8.1.1 China Biological Drugs Sales by Company (2016-2021)
8.1.2 China Biological Drugs Revenue by Company (2016-2021)
8.2 China Biological Drugs Sales Breakdown by Type
8.2.1 China Biological Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Biological Drugs Sales Breakdown by Type (2022-2027)
8.3 China Biological Drugs Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)
9 Japan Biological Drugs Market Facts & Figures
9.1 Japan Biological Drugs Sales by Company
9.1.1 Japan Biological Drugs Sales by Company (2016-2021)
9.1.2 Japan Biological Drugs Revenue by Company (2016-2021)
9.2 Japan Biological Drugs Sales Breakdown by Type
9.2.1 Japan Biological Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Biological Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Biological Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Biological Drugs Market Facts & Figures
10.1 Southeast Asia Biological Drugs Sales by Company
10.1.1 Southeast Asia Biological Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Biological Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Biological Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Biological Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Biological Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Biological Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Biological Drugs Market Facts & Figures
11.1 India Biological Drugs Sales by Company
11.1.1 India Biological Drugs Sales by Company (2016-2021)
11.1.2 India Biological Drugs Revenue by Company (2016-2021)
11.2 India Biological Drugs Sales Breakdown by Type
11.2.1 India Biological Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Biological Drugs Sales Breakdown by Type (2022-2027)
11.3 India Biological Drugs Sales Breakdown by Application
11.3.1 India Biological Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Biological Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Biological Drugs Business
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Corporation Information
12.1.2 Bristol-Myers Squibb Business Overview
12.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Corporation Information
12.2.2 Eli Lilly Business Overview
12.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly Biological Drugs Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Business Overview
12.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Biological Drugs Products Offered
12.3.5 Takeda Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Biological Drugs Products Offered
12.4.5 Pfizer Recent Development
12.5 Amgen
12.5.1 Amgen Corporation Information
12.5.2 Amgen Business Overview
12.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amgen Biological Drugs Products Offered
12.5.5 Amgen Recent Development
12.6 F. Hoffmann-La Roche
12.6.1 F. Hoffmann-La Roche Corporation Information
12.6.2 F. Hoffmann-La Roche Business Overview
12.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered
12.6.5 F. Hoffmann-La Roche Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Corporation Information
12.7.2 Johnson & Johnson Business Overview
12.7.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Johnson & Johnson Biological Drugs Products Offered
12.7.5 Johnson & Johnson Recent Development
12.8 Merck
12.8.1 Merck Corporation Information
12.8.2 Merck Business Overview
12.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merck Biological Drugs Products Offered
12.8.5 Merck Recent Development
12.9 Abbott Laboratories
12.9.1 Abbott Laboratories Corporation Information
12.9.2 Abbott Laboratories Business Overview
12.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Abbott Laboratories Biological Drugs Products Offered
12.9.5 Abbott Laboratories Recent Development
12.10 Baxter
12.10.1 Baxter Corporation Information
12.10.2 Baxter Business Overview
12.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Baxter Biological Drugs Products Offered
12.10.5 Baxter Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Business Overview
12.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Biological Drugs Products Offered
12.11.5 Novartis Recent Development
12.12 Biogen
12.12.1 Biogen Corporation Information
12.12.2 Biogen Business Overview
12.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biogen Biological Drugs Products Offered
12.12.5 Biogen Recent Development
12.13 GlaxoSmithKline
12.13.1 GlaxoSmithKline Corporation Information
12.13.2 GlaxoSmithKline Business Overview
12.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 GlaxoSmithKline Biological Drugs Products Offered
12.13.5 GlaxoSmithKline Recent Development
13 Biological Drugs Manufacturing Cost Analysis
13.1 Biological Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biological Drugs
13.4 Biological Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biological Drugs Distributors List
14.3 Biological Drugs Customers
15 Market Dynamics
15.1 Biological Drugs Market Trends
15.2 Biological Drugs Drivers
15.3 Biological Drugs Market Challenges
15.4 Biological Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Licenses Type
USD 4,000 Single License
USD 8,000 Enterprise License
BUY NOW Add to Cart
Why LBIR
Fastest report delivery service
More than 10 years of vast experience
Operational for 24 * 7 & 365 days
In-depth and comprehensive analysis
Excellent after sales support
Owns large database
Need Help ?
Email Us FAQ
Global Biological Drugs Sales market
1.1 Biological Drugs Product Scope
1.2 Biological Drugs Segment by Type
1.2.1 Global Biological Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Therapeutic Protein
1.2.3 Monoclonal Antibody
1.2.4 Vaccine
1.2.5 Others
1.3 Biological Drugs Segment by Application
1.3.1 Global Biological Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Biological Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Biological Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Biological Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Biological Drugs Price Trends (2016-2027)
2 Biological Drugs Estimates and Forecasts by Region
2.1 Global Biological Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Biological Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Biological Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Biological Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Biological Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Biological Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Biological Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Biological Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Biological Drugs Estimates and Projections (2016-2027)
2.4.3 China Biological Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Biological Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Biological Drugs Estimates and Projections (2016-2027)
2.4.6 India Biological Drugs Estimates and Projections (2016-2027)
3 Global Biological Drugs Competition Landscape by Players
3.1 Global Top Biological Drugs Players by Sales (2016-2021)
3.2 Global Top Biological Drugs Players by Revenue (2016-2021)
3.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biological Drugs as of 2020)
3.4 Global Biological Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Biological Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Biological Drugs Market Size by Type
4.1 Global Biological Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Biological Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Biological Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Biological Drugs Price by Type (2016-2021)
4.2 Global Biological Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Biological Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Biological Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Biological Drugs Price Forecast by Type (2022-2027)
5 Global Biological Drugs Market Size by Application
5.1 Global Biological Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Biological Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Biological Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Biological Drugs Price by Application (2016-2021)
5.2 Global Biological Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Biological Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Biological Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Biological Drugs Price Forecast by Application (2022-2027)
6 North America Biological Drugs Market Facts & Figures
6.1 North America Biological Drugs Sales by Company
6.1.1 North America Biological Drugs Sales by Company (2016-2021)
6.1.2 North America Biological Drugs Revenue by Company (2016-2021)
6.2 North America Biological Drugs Sales Breakdown by Type
6.2.1 North America Biological Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Biological Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Biological Drugs Sales Breakdown by Application
6.3.1 North America Biological Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Biological Drugs Sales Breakdown by Application (2022-2027)
7 Europe Biological Drugs Market Facts & Figures
7.1 Europe Biological Drugs Sales by Company
7.1.1 Europe Biological Drugs Sales by Company (2016-2021)
7.1.2 Europe Biological Drugs Revenue by Company (2016-2021)
7.2 Europe Biological Drugs Sales Breakdown by Type
7.2.1 Europe Biological Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Biological Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Biological Drugs Sales Breakdown by Application
7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)
8 China Biological Drugs Market Facts & Figures
8.1 China Biological Drugs Sales by Company
8.1.1 China Biological Drugs Sales by Company (2016-2021)
8.1.2 China Biological Drugs Revenue by Company (2016-2021)
8.2 China Biological Drugs Sales Breakdown by Type
8.2.1 China Biological Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Biological Drugs Sales Breakdown by Type (2022-2027)
8.3 China Biological Drugs Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)
9 Japan Biological Drugs Market Facts & Figures
9.1 Japan Biological Drugs Sales by Company
9.1.1 Japan Biological Drugs Sales by Company (2016-2021)
9.1.2 Japan Biological Drugs Revenue by Company (2016-2021)
9.2 Japan Biological Drugs Sales Breakdown by Type
9.2.1 Japan Biological Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Biological Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Biological Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Biological Drugs Market Facts & Figures
10.1 Southeast Asia Biological Drugs Sales by Company
10.1.1 Southeast Asia Biological Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Biological Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Biological Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Biological Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Biological Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Biological Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Biological Drugs Market Facts & Figures
11.1 India Biological Drugs Sales by Company
11.1.1 India Biological Drugs Sales by Company (2016-2021)
11.1.2 India Biological Drugs Revenue by Company (2016-2021)
11.2 India Biological Drugs Sales Breakdown by Type
11.2.1 India Biological Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Biological Drugs Sales Breakdown by Type (2022-2027)
11.3 India Biological Drugs Sales Breakdown by Application
11.3.1 India Biological Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Biological Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Biological Drugs Business
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Corporation Information
12.1.2 Bristol-Myers Squibb Business Overview
12.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Corporation Information
12.2.2 Eli Lilly Business Overview
12.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly Biological Drugs Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Business Overview
12.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Biological Drugs Products Offered
12.3.5 Takeda Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Biological Drugs Products Offered
12.4.5 Pfizer Recent Development
12.5 Amgen
12.5.1 Amgen Corporation Information
12.5.2 Amgen Business Overview
12.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amgen Biological Drugs Products Offered
12.5.5 Amgen Recent Development
12.6 F. Hoffmann-La Roche
12.6.1 F. Hoffmann-La Roche Corporation Information
12.6.2 F. Hoffmann-La Roche Business Overview
12.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered
12.6.5 F. Hoffmann-La Roche Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Corporation Information
12.7.2 Johnson & Johnson Business Overview
12.7.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Johnson & Johnson Biological Drugs Products Offered
12.7.5 Johnson & Johnson Recent Development
12.8 Merck
12.8.1 Merck Corporation Information
12.8.2 Merck Business Overview
12.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merck Biological Drugs Products Offered
12.8.5 Merck Recent Development
12.9 Abbott Laboratories
12.9.1 Abbott Laboratories Corporation Information
12.9.2 Abbott Laboratories Business Overview
12.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Abbott Laboratories Biological Drugs Products Offered
12.9.5 Abbott Laboratories Recent Development
12.10 Baxter
12.10.1 Baxter Corporation Information
12.10.2 Baxter Business Overview
12.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Baxter Biological Drugs Products Offered
12.10.5 Baxter Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Business Overview
12.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Biological Drugs Products Offered
12.11.5 Novartis Recent Development
12.12 Biogen
12.12.1 Biogen Corporation Information
12.12.2 Biogen Business Overview
12.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biogen Biological Drugs Products Offered
12.12.5 Biogen Recent Development
12.13 GlaxoSmithKline
12.13.1 GlaxoSmithKline Corporation Information
12.13.2 GlaxoSmithKline Business Overview
12.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 GlaxoSmithKline Biological Drugs Products Offered
12.13.5 GlaxoSmithKline Recent Development
13 Biological Drugs Manufacturing Cost Analysis
13.1 Biological Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biological Drugs
13.4 Biological Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biological Drugs Distributors List
14.3 Biological Drugs Customers
15 Market Dynamics
15.1 Biological Drugs Market Trends
15.2 Biological Drugs Drivers
15.3 Biological Drugs Market Challenges
15.4 Biological Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Licenses Type
USD 4,000 Single License
USD 8,000 Enterprise License
BUY NOW Add to Cart
Why LBIR
Fastest report delivery service
More than 10 years of vast experience
Operational for 24 * 7 & 365 days
In-depth and comprehensive analysis
Excellent after sales support
Owns large database
Need Help ?
Email Us FAQ
Global Biological Drugs Sales market
